Valeant Pharmaceuticals To Participate In September Healthcare Conferences

LAVAL, Quebec, Aug. 30, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences in September:

• Wells Fargo Healthcare Conference on Wednesday, September 7, at 3:30 p.m. ET at the Westin Waterfront Hotel in Boston; and,
• Morgan Stanley Global Healthcare Conference on Tuesday, September 13, at 9:10 a.m. ET at the Grand Hyatt Hotel in New York City.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations/2016.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:

Investors:
Elif McDonald
[e-mail]
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-in-september-healthcare-conferences-300320360.html

SOURCE Valeant Pharmaceuticals International, Inc.

Copyright 2016 PR Newswire